Tumour necrosis factor-α converting enzyme (TACE) activity in human colonic epithelial cellsKIRKEGAARD, T; PEDERSEN, G; SAERMARK, T et al.Clinical and experimental immunology (Print). 2004, Vol 135, Num 1, pp 146-153, issn 0009-9104, 8 p.Article

Rho GTPases and the regulation of endothelial permeabilityWOJCIAK-STOTHARD, Beata; RIDLEY, Anne J.Vascular pharmacology. 2002, Vol 39, Num 4-5, pp 187-199, issn 1537-1891, 13 p.Article

Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritisSMITH, R; TARNER, I. H; HOLLENHORST, M et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 15, pp 1248-1257, issn 0969-7128, 10 p.Article

Serum tumour necrosis factor-α and soluble tumour necrosis factor receptors levels in patients with Guillain-Barre syndromeRADHAKRISHNAN, V. V; SUMI, M. G; REUBEN, S et al.Acta neurologica scandinavica. 2004, Vol 109, Num 1, pp 71-74, issn 0001-6314, 4 p.Article

Cell cycle-specific effects of tumor necrosis factor = Effets spécifiques du cycle cellulaire du facteur de nécrose tumoraleDARZYNKIEWICZ, Z; WILLIAMSON, B; CARSWELL, E. A et al.Cancer research (Baltimore). 1984, Vol 44, Num 1, pp 83-90, issn 0008-5472Article

RESEARCH ON THE PRODUCTION SITE OF TUMOR NECROSIS FACTOR (TNF)SATOMI N; HARANAKA K; KUNII O et al.1981; JPN. J. EXP. MED.; ISSN 0021-5031; JPN; DA. 1981; VOL. 51; NO 6; PP. 317-322; BIBL. 14 REF.Article

Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopeniaZHU, Xiao-Juan; YAN SHI; FENG ZHANG et al.British journal of haematology. 2014, Vol 166, Num 5, pp 783-791, issn 0007-1048, 9 p.Article

Effects of sodium chloride on the production of bioactive exopolysaccharides in submerged cultures of Phellinus linteusSHU, Chin-Hang; HSU, Hui-Ju.Journal of chemical technology and biotechnology (1986). 2008, Vol 83, Num 5, pp 618-624, issn 0268-2575, 7 p.Article

Effects of treatment on soluble tumour necrosis factor receptor type 1 and 2 in chronic periodontitisIKEZAWA-SUZUKI, Ikuyo; SHIMADA, Yasuko; TAI, Hideaki et al.Journal of clinical periodontology. 2008, Vol 35, Num 11, pp 961-968, issn 0303-6979, 8 p.Article

Association between cigarette smoking and release of tumour necrosis factor α and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritisGLOSSOP, J. R; DAWES, P. T; MATTEY, D. L et al.Rheumatology (Oxford. Print). 2006, Vol 45, Num 10, pp 1223-1229, issn 1462-0324, 7 p.Article

Effects of culture temperature on the production of bioactive polysaccharides by Agaricus blazei in batch culturesSHU, Chin-Hang; LIN, Ko-Jung; WEN, Bor-Jiun et al.Journal of chemical technology and biotechnology (1986). 2007, Vol 82, Num 9, pp 831-836, issn 0268-2575, 6 p.Article

Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials : a survey of power considerationsYAZICI, Y; ADLER, N. M; YAZICI, H et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 7, pp 1054-1057, issn 1462-0324, 4 p.Article

Heterophile interference accounts for method-specific dsDNA antibodies in patients receiving anti-TNF treatmentALSHEKAILI, Jalila; LI, Candice; COOK, Matthew C et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 5, pp 891-897, issn 1462-0324, 7 p.Article

Immunogénicité des anti-TNFαSARAUX, A.La Lettre du rhumatologue. 2007, Num 336, pp 3-4, issn 0761-5027, 2 p., SUPArticle

Comparison of in vitro cell cytotoxic assays for tumor necrosis factorFLICK, D. A; GIFFORD, G. E.Journal of immunological methods. 1984, Vol 68, Num 1-2, pp 167-175, issn 0022-1759Article

Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparumHAIDARIS, C. G; HAYNES, J. D; MELTZER, M. S et al.Infection and immunity. 1983, Vol 42, Num 1, pp 385-393, issn 0019-9567Article

INHIBITION OF L-CELL GROWTH IN AGAROSE (ILGA): A SIMPLE INEXPENSIVE METHOD FOR THE DETECTION AND QUANTITATION OF FACTORS INHIBITING TUMOR CELL GROWTH = INHIBITION DE LA CROISSANCE DES CELLULES L EN AGAROSE (ILGA): UNE METHODE SIMPLE ET PEU COUTEUSE POUR LA MISE EN EVIDENCE ET LE DOSAGE DE FACTEURS INHIBANT LA CROISSANCE DES CELLULES TUMORALESPRINCE HE; ANDERSON WL; TOMASI TB et al.1982; J. IMMUNOL. METHODS; ISSN 0022-1759; NLD; DA. 1982; VOL. 48; NO 3; PP. 367-372; BIBL. 7 REF.Article

Effets paradoxaux des agents anti-TNFαWENDLING, D.La Lettre du rhumatologue. 2007, Num 336, pp 11-12, issn 0761-5027, 2 p., SUPArticle

Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase responseAROSTEGUI, Juan I; SOLIS, Pilar; ALDEA, Anna et al.European journal of pediatrics. 2005, Vol 164, Num 1, pp 13-16, issn 0340-6199, 4 p.Article

A novel bivalent single-chain variable fragment (scFV) inhibits the action of tumour necrosis factor αMENGYUAN LIU; XIANGBIN WANG; CHANGCHENG YIN et al.Biotechnology and applied biochemistry. 2008, Vol 50, pp 173-179, issn 0885-4513, 7 p., 3-4Article

Circulating soluble tumour necrosis factor receptors in patients with epidermodysplasia verruciformis as compared to patients with cutaneous tumours in the general populationMALEJCZYK, Magdalena; JOZWIAK, Jaroslaw; JABLONSKA, Stefania et al.Oncology reports. 2005, Vol 13, Num 1, pp 151-155, issn 1021-335X, 5 p.Article

The TRAIL-receptor-1 : TRAIL-receptor-3 and -4 ratio is a predictor for TRAIL sensitivity of cancer cellsBÜNEKER, Chirlei; MOHR, Andrea; ZWACKA, Ralf Michael et al.Oncology reports. 2009, Vol 21, Num 5, pp 1289-1295, issn 1021-335X, 7 p.Article

Experiences with tumour necrosis factor-α inhibitors in patients with juvenile idiopathic arthritis: Hungarian data from the National Institute of Rheumatology and Physiotherapy RegistrySEVCIC, Krisztina; ORBAN, Ilonka; BRODSZKY, Valentin et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 7, pp 1337-1340, issn 1462-0324, 4 p.Article

Alopecia Areata Universalis Elicited during Treatment with AdalimumabPELIVANI, Nedzmidin; HASSAN, Akmal S; BRAATHEN, Lasse R et al.Dermatology (Basel). 2008, Vol 216, Num 4, pp 320-323, issn 1018-8665, 4 p.Article

Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophagesDONNELLY, L. E; TUDHOPE, S. J; FENWICK, P. S et al.The European respiratory journal. 2010, Vol 36, Num 1, pp 178-186, issn 0903-1936, 9 p.Article